In this week’s episode, Joe and David meet up to talk about Vital, Convergence, and the latest news:  -Tryp Therapeutics and Mass General signing a letter of intent for a Phase 2 clinical trial investigating the effects of psilocybin-assisted psychotherapy for the treatment of Irritable Bowel Syndrome – interesting because it further highlights the likely […]

The post Psychedelics Weekly – Psilocybin-Assisted Psychotherapy for I.B.S., NY Aims to Legalize, and B.C.’s Decriminalization Experiment appeared first on Psychedelics Today.

Previous articleatai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression
Next articleLegally Psychedelic: The Regulatory Environment from Oregon to Colorado